PDS Biotech completes $11.3M PIPE led by Nant; adds Soon-Shiong and Banaag to board

PDS Biotechnology Corp

Initial closing: issued 16,502,870 shares, 23,498,156 pre-funded warrants, 20,000,514 common warrants; gross $11.3M.
Nant (Soon-Shiong) bought $10M of securities; Milestone Closing obligates Nant ($10M) and AB Group ($1M) to buy more.
Dr. Patrick Soon-Shiong (Class C) and James Banaag (Class A) appointed to board effective Sept 14, 2026.
Redeemed $6M Yorkville promissory note for ~$4.6M in full; no early termination penalties.
Proceeds to repay debt, working capital, and advance PDS0301 into late-stage development.

item 1.02 item 5.02 item 7.01 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

James Banaag

Director

PDSB · PDS Biotechnology Corp

Effective: 2026-09-14
Filed: September 14, 2026, 4:10 PM ET

the Board of Directors (the “ Board ”) of the Company appointed Dr. Patrick Soon-Shiong and Mr. James Banaag as directors and new members of the Board to fill the vacancies on the Board created from the previously announced increase in the size of the Board from six to eight directors, effective as of the Initial Closing (as defined in the Purchase Agreement), which occurred on September 14, 2026.

Appointed

Patrick Soon-Shiong

Director

PDSB · PDS Biotechnology Corp

Effective: 2026-09-14
Filed: September 14, 2026, 4:10 PM ET

the Board of Directors (the “ Board ”) of the Company appointed Dr. Patrick Soon-Shiong and Mr. James Banaag as directors and new members of the Board to fill the vacancies on the Board created from the previously announced increase in the size of the Board from six to eight directors, effective as of the Initial Closing (as defined in the Purchase Agreement), which occurred on September 14, 2026.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

James Banaag was appointed as Director at PDS Biotechnology Corp.

Action: appointed
Role: Director

Exact text from the filing

the Board of Directors (the “ Board ”) of the Company appointed Dr. Patrick Soon-Shiong and Mr. James Banaag as directors and new members of the Board to fill the vacancies on the Board created from the previously announced increase in the size of the Board from six to eight directors, effective as of the Initial Closing (as defined in the Purchase Agreement), which occurred on September 14, 2026.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Patrick Soon-Shiong was appointed as Director at PDS Biotechnology Corp.

Action: appointed
Role: Director

Exact text from the filing

the Board of Directors (the “ Board ”) of the Company appointed Dr. Patrick Soon-Shiong and Mr. James Banaag as directors and new members of the Board to fill the vacancies on the Board created from the previously announced increase in the size of the Board from six to eight directors, effective as of the Initial Closing (as defined in the Purchase Agreement), which occurred on September 14, 2026.

View on SEC.gov

PDS Biotechnology Corp filing history →

Source: SEC EDGAR

accession 0001140361-26-036489

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.